Bicentennial Bites: February
Celebrating 200 Years as Cincinnati's university
In celebration of the University of Cincinnati’s 200-year anniversary, we are proud to announce Bicentennial Bites.
February's Bicentennial Bites partner is Share: Cheesebar, a Pleasant Ridge cheese shop owned by UC alumna Emily Frank, A&S ’96. Share will be donating 20 percent of the proceeds of their six-piece combo (3
What is Bicentennial Bites, you ask?
In 2019, UC will partner with select Cincinnati restaurants, each on a monthly basis, to provide a special deal or commemorative item for all Boldly Bearcats. When you purchase the specialty item, a portion of the proceeds will come back to UC to support scholarships. Now that’s #boldlybearcat.
Want to participate? Use #bicentennialbites and #boldlybearcat on social media when you enjoy your Bicentennial Bites and be entered to win a prize.
Can't get enough Bicentennial?
Visit 200.uc.edu for a list of ways to get involved and celebrate the University of Cincinnati's 200-year anniversary.
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.